Laurence A Turka

Years Active: 2018-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Xuqing Zhang, Mengyao Luo, Shamael R Dastagir, Mellissa Nixon, Annie Khamhoung, Andrea Schmidt, Albert Lee, Naren Subbiah, Douglas C McLaughlin, Christopher L Moore, Mary Gribble, Nicholas Bayhi, Viral Amin, Ryan Pepi, Sneha Pawar, Timothy J Lyford, Vikram Soman, Jennifer Mellen, Christopher L Carpenter, Laurence A Turka, Thomas J Wickham, Tiffany F Chen
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic. Nature communications 12 (1) (2021)
Hossam A Abdelsamed, Caitlin C Zebley, Hai Nguyen, Rachel L Rutishauser, Yiping Fan, Hazem E Ghoneim, Jeremy Chase Crawford, Francesca Alfei, Shanta Alli, Susan Pereira Ribeiro, Ashley H Castellaw, Maureen A McGargill, Hongjian Jin, Shannon K Boi, Cate Speake, Elisavet Serti, Laurence A Turka, Michael E Busch, Mars Stone, Steven G Deeks, Rafick-Pierre Sekaly, Dietmar Zehn, Eddie A James, Gerald T Nepom, Benjamin A Youngblood
Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes. Nature immunology 21 (5) (2020)
Ryan H Newton, Sharad Shrestha, Jenna M Sullivan, Kathleen B Yates, Ewoud B Compeer, Noga Ron-Harel, Bruce R Blazar, Steven J Bensinger, W Nicholas Haining, Michael L Dustin, Daniel J Campbell, Hongbo Chi, Laurence A Turka
Maintenance of CD4 T cell fitness through regulation of Foxo1. Nature immunology 19 (8) (2018)

Laurence A Turka.css-eqlu8i{font-size:small;padding-left:4px;}